179 related articles for article (PubMed ID: 19141588)
1. Effect of hyperglycemia on mitochondrial respiration in type 2 diabetes.
Rabøl R; Højberg PM; Almdal T; Boushel R; Haugaard SB; Madsbad S; Dela F
J Clin Endocrinol Metab; 2009 Apr; 94(4):1372-8. PubMed ID: 19141588
[TBL] [Abstract][Full Text] [Related]
2. Opposite effects of pioglitazone and rosiglitazone on mitochondrial respiration in skeletal muscle of patients with type 2 diabetes.
Rabøl R; Boushel R; Almdal T; Hansen CN; Ploug T; Haugaard SB; Prats C; Madsbad S; Dela F
Diabetes Obes Metab; 2010 Sep; 12(9):806-14. PubMed ID: 20649633
[TBL] [Abstract][Full Text] [Related]
3. Regional anatomic differences in skeletal muscle mitochondrial respiration in type 2 diabetes and obesity.
Rabøl R; Larsen S; Højberg PM; Almdal T; Boushel R; Haugaard SB; Andersen JL; Madsbad S; Dela F
J Clin Endocrinol Metab; 2010 Feb; 95(2):857-63. PubMed ID: 20061415
[TBL] [Abstract][Full Text] [Related]
4. Improved glycaemic control decreases inner mitochondrial membrane leak in type 2 diabetes.
Rabøl R; Højberg PM; Almdal T; Boushel R; Haugaard SB; Madsbad S; Dela F
Diabetes Obes Metab; 2009 Apr; 11(4):355-60. PubMed ID: 19267714
[TBL] [Abstract][Full Text] [Related]
5. Biphasic insulin aspart 30: better glycemic control than with premixed human insulin 30 in obese patients with Type 2 diabetes.
Velojic-Golubovic M; Mikic D; Pesic M; Dimic D; Radenkovic S; Antic S
J Endocrinol Invest; 2009 Jan; 32(1):23-7. PubMed ID: 19337010
[TBL] [Abstract][Full Text] [Related]
6. Metformin-treated patients with type 2 diabetes have normal mitochondrial complex I respiration.
Larsen S; Rabøl R; Hansen CN; Madsbad S; Helge JW; Dela F
Diabetologia; 2012 Feb; 55(2):443-9. PubMed ID: 22009334
[TBL] [Abstract][Full Text] [Related]
7. Twice daily biphasic insulin aspart improves postprandial glycaemic control more effectively than twice daily NPH insulin, with low risk of hypoglycaemia, in patients with type 2 diabetes.
Christiansen JS; Vaz JA; Metelko Z; Bogoev M; Dedov I
Diabetes Obes Metab; 2003 Nov; 5(6):446-54. PubMed ID: 14617231
[TBL] [Abstract][Full Text] [Related]
8. Biphasic insulin aspart 30 improved glycemic control in Chinese patients with type 2 diabetes poorly controlled on oral glucose-lowering drugs: a subgroup analysis of the A₁chieve study.
Chen L; Xing X; Lei M; Liu J; Shi Y; Li P; Qin G; Li C; Li Y; Wang Q; Gao T; Hu L; Wang Y; Yang W
Chin Med J (Engl); 2014; 127(2):208-12. PubMed ID: 24438605
[TBL] [Abstract][Full Text] [Related]
9. Comparison of fasting capillary glucose variability between insulin glargine and NPH.
Mu P; Lu H; Zhang G; Chen Y; Fu J; Wang M; Shu J; Zeng L
Diabetes Res Clin Pract; 2011 Jan; 91(1):e4-7. PubMed ID: 20970870
[TBL] [Abstract][Full Text] [Related]
10. Insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Asian patients with type 2 diabetes inadequately controlled on basal or pre-/self-mixed insulin: a 26-week, randomised, treat-to-target trial.
Kaneko S; Chow F; Choi DS; Taneda S; Hirao K; Park Y; Andersen TH; Gall MA; Christiansen JS;
Diabetes Res Clin Pract; 2015 Jan; 107(1):139-47. PubMed ID: 25498130
[TBL] [Abstract][Full Text] [Related]
11. Waist circumference reduction after insulin detemir therapy in type 2 diabetes patients previously treated with NPH.
Mandosi E; Fallarino M; Rossetti M; Gatti A; Morano S
Diabetes Res Clin Pract; 2009 May; 84(2):e18-20. PubMed ID: 19297054
[TBL] [Abstract][Full Text] [Related]
12. The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.
Robinson AC; Burke J; Robinson S; Johnston DG; Elkeles RS
Diabetes Care; 1998 May; 21(5):701-5. PubMed ID: 9589227
[TBL] [Abstract][Full Text] [Related]
13. Insulin detemir improves glycemic control and reduces hypoglycemia in children with type 1 diabetes: findings from the Turkish cohort of the PREDICTIVE observational study.
Kurtoglu S; Atabek ME; Dizdarer C; Pirgon O; Isguven P; Emek S;
Pediatr Diabetes; 2009 Sep; 10(6):401-7. PubMed ID: 19220776
[TBL] [Abstract][Full Text] [Related]
14. Use of glargine in pregnant women with type 1 diabetes mellitus: a case-control study.
Imbergamo MP; Amato MC; Sciortino G; Gambina M; Accidenti M; Criscimanna A; Giordano C; Galluzzo A
Clin Ther; 2008 Aug; 30(8):1476-84. PubMed ID: 18803989
[TBL] [Abstract][Full Text] [Related]
15. Risk for nocturnal hypoglycemia with biphasic insulin aspart 30 compared with biphasic human insulin 30 in adults with type 2 diabetes mellitus: a meta-analysis.
Davidson JA; Liebl A; Christiansen JS; Fulcher G; Ligthelm RJ; Brown P; Gylvin T; Kawamori R
Clin Ther; 2009 Aug; 31(8):1641-51. PubMed ID: 19808125
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological treatment of the pathogenetic defects in type 2 diabetes: the randomized multicenter South Danish Diabetes Study.
Gram J; Henriksen JE; Grodum E; Juhl H; Hansen TB; Christiansen C; Yderstræde K; Gjessing H; Hansen HM; Vestergaard V; Hangaard J; Beck-Nielsen H
Diabetes Care; 2011 Jan; 34(1):27-33. PubMed ID: 20929990
[TBL] [Abstract][Full Text] [Related]
17. Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901) and NPH insulin.
Rosenstock J; Schwartz SL; Clark CM; Park GD; Donley DW; Edwards MB
Diabetes Care; 2001 Apr; 24(4):631-6. PubMed ID: 11315821
[TBL] [Abstract][Full Text] [Related]
18. Addition of biphasic insulin aspart 30 to rosiglitazone in type 2 diabetes mellitus that is poorly controlled with glibenclamide monotherapy.
Raz I; Mouritzen U; Vaz J; Hershkovitz T; Wainstein J; Harman-Boehm I
Clin Ther; 2003 Dec; 25(12):3109-23. PubMed ID: 14749149
[TBL] [Abstract][Full Text] [Related]
19. Twice-daily insulin degludec/insulin aspart provides superior fasting plasma glucose control and a reduced rate of hypoglycaemia compared with biphasic insulin aspart 30 in insulin-naïve adults with Type 2 diabetes.
Franek E; Haluzík M; Canecki Varžić S; Sargin M; Macura S; Zacho J; Christiansen JS
Diabet Med; 2016 Apr; 33(4):497-505. PubMed ID: 26435365
[TBL] [Abstract][Full Text] [Related]
20. Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with type 1 diabetes.
Hermansen K; Fontaine P; Kukolja KK; Peterkova V; Leth G; Gall MA
Diabetologia; 2004 Apr; 47(4):622-9. PubMed ID: 15298338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
